Current track



Government announces plan to extend gap between AstaZeneca vaccine doses to 16 weeks

Written by on May 2, 2021

The Government has confirmed that it will be extending the gap between the first and second doeses of the AstaZeneca coronavirus vaccine to 16 weeks.

Spain becomes the first country to diverge from the guidance issued by the European Medicinces Agency, and leaves Spain responsible for any side-effects caused due to the extension.

The current approval for the vaccine is based on the second dose being administered between four to 12 weeks after the first. A 16-week interval has not been tested in any human trials.

Meanwhile the infection rate fell on Friday, down to 229 cases per 100,000 people compared with 230 on Thursday, according to health ministry data.